Pelthos Therapeutics Inc. (PTHS)
↓ Download CSV- Sector Manufacturing
- Incorporated NV
- Fiscal year ends Dec 31
In fiscal 2025, Pelthos Therapeutics Inc. reported revenue of $16.80M. The company ran a net loss, with a net margin of -257.9%. It held $130.40M in total assets against $91.52M in total liabilities.
Key ratios (FY2025)
-193.1%
Operating margin
-257.9%
Net margin
-111.4%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $16.80M | $0 | — | — | — |
| Cost of Revenue | $3.99M | $0 | — | — | — |
| Operating Income | -$32.43M | -$7.57M | -$6.86M | -$2.32M | — |
| Net Income | -$43.32M | -$7.96M | -$7.38M | -$2.46M | — |
| EPS (Diluted) | $-23.04 | $-14.27 | $-5.78 | $5.65 | — |
| Total Assets | $130.40M | $1.37M | $96.4K | $55.1K | — |
| Total Liabilities | $91.52M | $4.08M | $6.54M | $3.76M | — |
| Shareholders' Equity | $38.88M | -$2.71M | -$6.45M | -$3.71M | -$3.68M |
| Cash & Equivalents | $17.97M | $513.0K | $100.0K | $100.0K | — |
| Operating Cash Flow | -$22.59M | -$5.79M | -$981.0K | -$1.57M | — |
| Capital Expenditures | $99.0K | $0 | — | — | — |
| Shares Outstanding | 3.23M | 610.4K | 3.91M | 1.11M | — |